New drug aims to boost brain function in fragile x patients
NCT ID NCT07439510
First seen Feb 28, 2026 · Last updated May 13, 2026 · Updated 10 times
Summary
This study tests a new drug called SPG601 to see if it can improve thinking and learning in adult men with Fragile X syndrome. About 248 men aged 18 to 45 will take either the drug or a placebo (a dummy pill) for several months. The main goal is to measure changes in cognitive abilities using brain tests and EEG scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAGILE-X SYNDROME (FXS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.